57 varieties: The human cytochromes P450

Pharmacogenomics

Volumn 5, Issue 3, 2004, Pages 305-318

  Lewis, David F V ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Cytochrome P450; Human drug metabolism; Molecular modeling

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; ESTRADIOL; FATTY ACID; FLUCONAZOLE; FORMESTANE; FURAFYLLINE; ICOSANOID; ISOENZYME; KETOCONAZOLE; ORPHENADRINE; PILOCARPINE; PROSTANOID; PYRIDINE; QUINIDINE; STEROID; SULFAPHENAZOLE; SULFINPYRAZONE; TESTOSTERONE; UNINDEXED DRUG; XENOBIOTIC AGENT;

DEALKYLATION; DRUG METABOLISM; DRUG POTENCY; ENZYME ACTIVE SITE; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME SUBSTRATE; FATTY ACID METABOLISM; GENE SEQUENCE; HORMONE SYNTHESIS; HUMAN; HYDROXYLATION; ICOSANOID METABOLISM; OXIDATION; PEROXIDATION; PROTEIN FAMILY; PROTEIN FUNCTION; REDUCTION; REVIEW; STEROID METABOLISM; XENOBIOTIC METABOLISM;

CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; ISOENZYMES; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; XENOBIOTICS;

HOMO; HOMO SAPIENS;

EID: 6344250770     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/phgs.5.3.305.29827     Document Type: Review

References (26)

1. Rendic S, DiCarlo FJ: Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metab. Rev. 29, 413-580 (1997).
2. Anzenbacher P, Anzenbacherova E: Cytochrome P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 58, 737-747 (2001).
3. Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab. Rev. 34, 83-448 (2002).
4. Guengerich FP: Human cytochrome P450 enzymes. In: Cytochrome P450. PR Ortiz de Montellano (Ed.), Plenum, New York, Chapter 14, 473-535 (1995).
5. Guengerich FP: Cytochrome P450. In: Enzyme Systems that Metabolize Drugs and Other Xenobiotics. C Ioannides (Ed.), Wiley, New York, Chapter 2, 33-65 (2002).
6. Guengerich FP: Update information on human P450s. Drug Metab. Rev. 34, 7-15 (2002).
7. Hodgson E: In vitro human phase 1 metabolism of xenobiotics: 1: pesticides and related chemicals used in agriculture and public health. J. Biochem. Mol. Toxicol. 13, 296-299 (2001).
8. Nelson DR: Introductory remarks on human CYPs. Drug Metab. Rev. 34, 1-5 (2002).
9. Lewis DFV, Dickins M: Substrate SARs in human P450s. Drug Discov. Today 7, 918-925 (2002).
10. Waxman DJ, Chang TKH: Hormonal regulation of liver cytochrome P450 enzymes. In: Cytochrome P450. PR Ortiz de Montellano (Ed.), Plenum, New York, Chapter 11, 391-417 (1995).
11. Lewis DFV: Guide to Cytochromes P450 Structure and Function. Taylor & Francis, London (2001).
12. Jacobs MN, Lewis DFV: Steroid hormone receptors and dietary ligands: a selected review. Proc. Nutr. Soc. 61, 105-122 (2002).
13. Lewis DFV: Cytochromes P450: Structure, Function and Mechanism. Taylor & Francis, London (1996).
14. Lewis DFV: Homology modelling of human CYP2 family enzyme based on the CYP2C5 crystal structure. Xenobiotica 32, 305-323 (2002).
15. Lewis DFV: Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template. J. Inorg. Biochem. 91, 502-514 (2002).
16. Lewis DFV: Molecular modeling of human cytochrome P450-substrate interactions. Drug Metab. Rev. 34, 55-67 (2002).
17. Williams PA, Cosme J, Ward A, Angove HC, Vinkovic DM, Jhoti H: Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 424, 464-468 (2003).
18. D values. Curr. Drug Metab. 4, 331-340 (2003).
19. Evans WE, Relling MV: Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286, 487-491 (1999).
20. Ingelman-Sundberg M: Implications of polymorphic cytochrome P450-dependent drug metabolism for drug development. Drug Metab. Dispos. 29, 570-573 (2001).
21. Ingelman-Sundberg M, Oscarson M, McLellan RA: Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. J. Pharm. Sci. 20, 342-349 (1999).
22. Kato S, Onda M, Matsukura N et al.: Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease. Pharmacogenetics 5, 5141-5144 (1995).
23. Honkakoski P, Negishi M: Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347, 321-337 (2000).
24. Waxman DJ: P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR and PPAR. Arch. Biochem. Biophys. 369, 11-23 (1999).
25. Gibson GG, Skett P: Introduction to Drug Metabolism (3rd edn). Nelson Thornes, Chichester (2001).
26. Korolev D, Balakin KV, Nikolsky Y et al: Modelling of human cytochrome P450-mediated drug metabolism using unsupervised machine learning approach. J. Med. Chem. 46, 3631-3643 (2003).